Scientists and engineers teamed up to use robots to streamline cell therapy manufacturing, aiming to give more patients access to these lifesaving therapies.
T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.
By activating CAR T cells only in the presence of an antibody switch, Travis Young and his team hope to make this cancer treatment safer and more effective.